AAAAAA

   
Results: 1-25 | 26-48 |
Results: 26-48/48
A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12
Authors: Panelli, MC Bettinotti, MP Lally, K Ohnmacht, GA Li, Y Robbins, P Riker, A Rosenberg, SA Marincola, FM
Citation: Mc. Panelli et al., A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12, J IMMUNOL, 164(8), 2000, pp. 4382-4392
Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases
Authors: Panelli, MC Riker, A Kammula, U Wang, E Lee, KH Rosenberg, SA Marincola, FM
Citation: Mc. Panelli et al., Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases, J IMMUNOL, 164(1), 2000, pp. 495-504
Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma
Authors: Ohnmacht, GA Marincola, FM
Citation: Ga. Ohnmacht et Fm. Marincola, Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma, J CELL PHYS, 182(3), 2000, pp. 332-338
Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes
Authors: Riker, AI Kammula, US Panelli, MC Wang, E Ohnmacht, GA Steinberg, SM Rosenberg, SA Marincola, FM
Citation: Ai. Riker et al., Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes, INT J CANC, 86(6), 2000, pp. 818-826
Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease - Sex-based differences in inflammation and type of immune response
Authors: Zhu, JH Shearer, GM Norman, JE Pinto, LA Marincola, FM Prasad, A Waclawiw, MA Csako, G Quyyumi, AA Epstein, SE
Citation: Jh. Zhu et al., Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease - Sex-based differences in inflammation and type of immune response, CIRCULATION, 102(20), 2000, pp. 2491-2496
Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma - Fixation methods yield variable results
Authors: Fetsch, PA Riker, AI Marincola, FM Abati, A
Citation: Pa. Fetsch et al., Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma - Fixation methods yield variable results, CANC CYTOP, 90(4), 2000, pp. 252-257
Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?
Authors: Fetsch, PA Marincola, FM Abati, A
Citation: Pa. Fetsch et al., Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?, DIAGN CYTOP, 20(6), 1999, pp. 393-396
Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?
Authors: Fetsch, PA Marincola, FM Abati, A
Citation: Pa. Fetsch et al., Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?, DIAGN CYTOP, 20(4), 1999, pp. 249-252
High-resolution HLA-A0201 subtyping using directed heteroduplex analysis
Authors: Kicklighter, EJ Lee, KH Barracchini, KC Bettinotti, M Norris, R Simonis, TB Stroncek, D Marincola, FM
Citation: Ej. Kicklighter et al., High-resolution HLA-A0201 subtyping using directed heteroduplex analysis, J IMMUNOTH, 22(3), 1999, pp. 219-228
HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
Authors: Hicklin, DJ Marincola, FM Ferrone, S
Citation: Dj. Hicklin et al., HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story, MOL MED TOD, 5(4), 1999, pp. 178-186
Cancer immunotherapy: Is there real progress at last?
Authors: Kammula, US Marincola, FM
Citation: Us. Kammula et Fm. Marincola, Cancer immunotherapy: Is there real progress at last?, BIODRUGS, 11(4), 1999, pp. 249-260
Cancer therapy using a self-replicating RNA vaccine
Authors: Ying, H Zaks, TZ Wang, RF Irvine, KR Kammula, US Marincola, FM Leitner, WW Restifo, NP
Citation: H. Ying et al., Cancer therapy using a self-replicating RNA vaccine, NAT MED, 5(7), 1999, pp. 823-827
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
Authors: Rosenberg, SA Yang, JC Schwartzentruber, DJ Hwu, P Marincola, FM Topalian, SL Seipp, CA Einhorn, JH White, DE Steinberg, SM
Citation: Sa. Rosenberg et al., Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b, J CL ONCOL, 17(3), 1999, pp. 968-975
Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma
Authors: Riker, AI Panelli, MC Kammula, US Wang, E Wunderlich, J Abati, A Fetsch, P Rosenberg, SA Marincola, FM
Citation: Ai. Riker et al., Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma, CANCER DET, 23(5), 1999, pp. 387-396
The new melanoma markers: MART-1 and melan-A (the NIH experience)
Authors: Fetsch, PA Marincola, FM Abati, A
Citation: Pa. Fetsch et al., The new melanoma markers: MART-1 and melan-A (the NIH experience), AM J SURG P, 23(5), 1999, pp. 607-609
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine
Authors: Rosenberg, SA Yang, JC Schwartzentruber, DJ Hwu, P Marincola, FM Topalian, SL Restifo, NP Sznol, M Schwarz, SL Spiess, PJ Wunderlich, JR Seipp, CA Einhorn, JH Rogers-Freezer, L White, DE
Citation: Sa. Rosenberg et al., Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine, J IMMUNOL, 163(3), 1999, pp. 1690-1695
Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
Authors: Kammula, US Lee, KH Riker, AI Wang, E Ohnmacht, GA Rosenberg, SA Marincola, FM
Citation: Us. Kammula et al., Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens, J IMMUNOL, 163(12), 1999, pp. 6867-6875
Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but doesnot lead to tumor regression
Authors: Lee, KH Wang, E Nielsen, MB Wunderlich, J Migueles, S Connors, M Steinberg, SM Rosenberg, SA Marincola, FM
Citation: Kh. Lee et al., Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but doesnot lead to tumor regression, J IMMUNOL, 163(11), 1999, pp. 6292-6300
A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology
Authors: Roden, MM Lee, KH Panelli, MC Marincola, FM
Citation: Mm. Roden et al., A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology, J IMMUNOL M, 226(1-2), 1999, pp. 29-41
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
Authors: Wang, ZG Marincola, FM Rivoltini, L Parmiani, G Ferrone, S
Citation: Zg. Wang et al., Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells, J EXP MED, 190(2), 1999, pp. 205-215
Natural variation of the expression of HLA and endogenous antigen modulates ctl recognition in an in vitro melanoma model
Authors: Cormier, JN Panelli, MC Hackett, JA Bettinotti, MP Mixon, A Wunderlich, J Parker, LL Restifo, NP Ferrone, S Marincola, FM
Citation: Jn. Cormier et al., Natural variation of the expression of HLA and endogenous antigen modulates ctl recognition in an in vitro melanoma model, INT J CANC, 80(5), 1999, pp. 781-790
Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells
Authors: Murakami, M Gurski, KJ Marincola, FM Ackland, J Steller, MA
Citation: M. Murakami et al., Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells, CANCER RES, 59(6), 1999, pp. 1184-1187
Melanoma-associated antigen recognized by T cells (MART-1) - The advent ofa preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration
Authors: Fetsch, PA Marincola, FM Filie, A Hijazi, YM Kleiner, DE Abati, A
Citation: Pa. Fetsch et al., Melanoma-associated antigen recognized by T cells (MART-1) - The advent ofa preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration, CANC CYTOP, 87(1), 1999, pp. 37-42
Risultati: 1-25 | 26-48 |